Jacobs Levy Equity Management Inc. Boosts Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Jacobs Levy Equity Management Inc. raised its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 105.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 76,346 shares of the company's stock after buying an additional 39,156 shares during the period. Jacobs Levy Equity Management Inc. owned about 0.14% of Astrana Health worth $2,407,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Handelsbanken Fonder AB grew its position in shares of Astrana Health by 4.7% during the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after acquiring an additional 400 shares during the period. Quarry LP raised its holdings in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after purchasing an additional 471 shares during the period. Swiss National Bank lifted its position in Astrana Health by 1.1% during the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after purchasing an additional 1,000 shares in the last quarter. MetLife Investment Management LLC grew its holdings in Astrana Health by 4.7% during the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock valued at $829,000 after purchasing an additional 1,173 shares during the period. Finally, Envestnet Asset Management Inc. grew its holdings in Astrana Health by 19.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after purchasing an additional 1,184 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ASTH. Bank of America decreased their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th. Robert W. Baird decreased their target price on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Barclays initiated coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price target on the stock. Stifel Nicolaus dropped their price target on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Finally, Truist Financial reduced their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Price Performance

ASTH stock traded down $0.72 during midday trading on Wednesday, hitting $26.37. The company's stock had a trading volume of 29,569 shares, compared to its average volume of 287,177. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health, Inc. has a 12 month low of $23.12 and a 12 month high of $63.20. The company has a 50 day moving average of $30.70 and a two-hundred day moving average of $34.90. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of 20.32, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $620.39 million during the quarter, compared to analysts' expectations of $628.11 million. During the same period last year, the firm posted $0.31 EPS. Astrana Health's quarterly revenue was up 53.4% compared to the same quarter last year. On average, analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.